%0 Journal Article
%T Shaping markets to benefit global health ¨C A 15-year history and lessons learned from the pentavalent vaccine market
%A Andrew Jones
%A Aurelia Nguyen
%A Edward Baker
%A Gian Gandhi
%A Melissa Malhame
%A Philipp Kalpaxis
%A Robyn Iqbal
%A Yalda Momeni
%J Archive of "Vaccine: X".
%D 2019
%R 10.1016/j.jvacx.2019.100033
%K Market shaping
%K Global health
%K Vaccines
%K Immunisation
%K Pentavalent
%K Market dynamics US$
%K United States Dollar
%K B
%K billion
%K BMGF
%K The Bill & Melinda Gates Foundation
%K DALY
%K disability-adjusted life-years
%K DTP
%K diphtheria tetanus pertussis vaccine
%K DTwP
%K diphtheria tetanus whole-cell pertussis vaccine
%K Gavi
%K Gavi The Vaccine Alliance
%K HepB
%K hepatitis B vaccine
%K Hib
%K haemophilus influenzae type b vaccine
%K HMF
%K Healthy Market Framework
%K IPV
%K inactivated polio virus
%K M
%K million
%K MIC
%K middle-income country
%K NRA
%K National Regulatory Authority
%K PAHO
%K Pan American Health Organization
%K Roadmap
%K Supply and Procurement Roadmap
%K PRG
%K Procurement Reference Group
%K SPS
%K Supply and Procurement Strategy
%K WAP
%K weighted average price
%K WHO
%K World Health Organization
%U https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6668221/